Learn more about whether Globus Medical, Inc. or LeMaitre Vascular, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

In an effort to help travel advisors elevate their social media presence, Globus has partnered with social-media management ...

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Investors need to pay close attention to Globus Medical (GMED) stock based on the movements in the options market lately.

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak ...

Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the ...

Globus Medical GMED +0.38% Get Free Report has outperformed the market over the past 10 years by 1.4% on an annualized basis ...

RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Globus Medical (GMED – Research Report) on April 15 and set a price target ...

GE Healthcare and Medtronic said they are preparing mitigation plans as they assess the potential ramifications of Trump’s ...

BTIG lowered the firm’s price target on Globus Medical (GMED) to $88 from $94 and keeps a Buy rating on the shares as part of a broader ...

Detailed price information for Globus Medical Inc (GMED-N) from The Globe and Mail including charting and trades.

In the assessment of 12-month price targets, analysts unveil insights for Globus Medical, presenting an average target of $90 ...